Patents
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
03/2006
03/15/2006EP1633725A1 Hepatitis c virus inhibitors
03/15/2006EP1633724A1 Phthalazinone derivatives
03/15/2006EP1633722A2 Preparation and use of aryl alkyl acid derivatives for the treatment of obesity
03/15/2006EP1633717A1 New p2x7 receptor antagonists and their use
03/15/2006EP1633710A1 Isoindolin-1-one compounds as kinase inhibitors
03/15/2006EP1633709A1 Anti-diabetic agents
03/15/2006EP1633355A1 Benzothiazole derivatives and use thereof in the treatment of diseases related to the adenosine a2a receptor
03/15/2006EP1633349A1 4-bromo-5- (2-chloro-benzoylamino)-1h-pyrazole-3-carboxylic acid (1-(aminocarbonyl) eth-1-yl) amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases
03/15/2006EP1633348A1 4- BROMO - 5 - (2- CHLORO - BENZOYLAMINO) - 1H - PYRAZOLE - 3 - CARBOXYLIC ACID AMIDE DERIVATIVES AND RELATED COMPOUNDS AS BRADYKININ B sb 1 /sb RECEPTOR ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY DISEASES
03/15/2006EP1633343A1 3-aminomethyl-pyrrolidines as n-type calcium channel blockers
03/15/2006EP1401435B1 Topical application of thiazolyl amides
03/15/2006EP1326864B1 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents
03/15/2006EP1309589B1 Urea compounds and methods of uses
03/15/2006EP1296679B1 Dermal therapeutic system containing non-steroidal antiphlogistics with selective cox-2 inhibition
03/15/2006EP0997147B1 Amino acid derivatives
03/15/2006CN1747951A Novel 2-pyridinecarboxamide derivatives
03/15/2006CN1747938A Novel substituted 2,3-benzodiazepine derivatives
03/15/2006CN1747936A Substituted azole derivatives as therapeutic agents
03/15/2006CN1747732A 2-aminocarbonyl-quinoline compounds as platelet adenosine diphosphate receptor antagonists
03/15/2006CN1746169A Preparation of 4-amino-1-(2-methylol-1,3-oxapentane-5-group)-2(1H)-pyrimidone
03/15/2006CN1245660C Color coupler for forming dye, silver halide photosensitive material and azomethine dyes compounds
03/15/2006CN1245401C 6-aryl-4-aminopicolinates and their use as herbicides
03/15/2006CN1245400C N-substituted benzothiophenesulfonamide derivatives
03/15/2006CN1245394C Substituted phenylacetamides and their use as glucokinase activators
03/15/2006CN1245386C 1,2-dihydropyridine compounds, process for preparation of same and use thereof
03/15/2006CN1245385C Indole and dihydroindole derivatives
03/14/2006US7012094 such as 3-(4-fluorophenyl)-4-(methylsulfonylphenyl)furan; for treatment of arthritis
03/14/2006US7012085 As antipsychotics in therapy of schizophrenia, depression, bipolar disorders, cognition deficits, Parkinson disease, drug abuse, attention deficit hyperactivity disorders, glaucoma, diabetes and erectile dysfunction
03/14/2006US7012084 Acylated piperidine derivatives as melanocortin-4 receptor agonists
03/14/2006US7012083 For prophylaxis and therapy of pruritus
03/14/2006US7012075 Cathepsin cysteine protease inhibitors
03/14/2006US7011918 Polymeric charge transport compositions for organophotoreceptors
03/14/2006US7011875 Optical information-recording medium and dye
03/14/2006CA2359363C 4-(heterocyclylsulfonamido)-5-methoxy-6-(2-methoxyphenoxy)-2-phenyl- or pyridylpyrimidines as endothelin receptor antagonists
03/14/2006CA2278241C Phenyl heterocycles as cyclooxygenase-2 inhibitors
03/14/2006CA2269531C Substituted benzoylaminothiazole derivatives and drugs containing the same
03/14/2006CA2239547C Benzazepine derivatives with vasopressin agonistic activity
03/14/2006CA2237005C Quinazoline derivatives
03/09/2006WO2006026204A2 Novel gamma-lactams as beta-secretase inhibitors
03/09/2006WO2006026053A1 Catalytics asymmetric activation of unactivated c-h bonds, and compounds related thereto
03/09/2006WO2006025979A2 Modulators of nuclear receptors
03/09/2006WO2006024823A1 Pyrimidine sulphonamide derivatives as chemokine receptor modulators
03/09/2006WO2006024820A1 Isoxazoline derivatives and their use as herbicides
03/09/2006WO2006024699A1 Thioxothiazolidinone compounds for use as pharmaceuticals
03/09/2006WO2005058841A3 Hiv protease inhibiting compounds
03/09/2006US20060052612 Bis-4,7-(5'-(2-fluorophenyl)-2'-thienyl)-2,1,3-benzothiadiazole; emission color of the compounds of can be adjusted over the entire visible region, i.e. from deep blue to deep red, by choice of an appropriate substitution pattern; high current densities
03/09/2006US20060052605 1,4-disubstituted piperazine compounds; for example 2-{4-[2-(acetylamino)-3-(2-methylbenzothiazol-5-yloxy)propyl]piperazinyl}-N-(3-phenylphenyl)acetamide; cardiovascular diseases such as arrhythmias, intermittent claudication, angina, congestive heart disease, diabetes, and myocardial infarction
03/09/2006US20060052603 Process for preparing substituted phenoxy-acetic acids from phenols
03/09/2006US20060052600 Amino-functional chalcones
03/09/2006US20060052597 Aryloxyalkylamine derivatives as h3 receptor ligands
03/09/2006US20060052595 Heterocyclic compounds as ccr5 antagonists
03/09/2006US20060052426 Acylaminothiazole derivatives, their preparation and their therapeutic use
03/09/2006US20060052420 Thiazolo-naphthyl acids
03/09/2006US20060052418 Viral polymerase inhibitors
03/09/2006US20060052416 2-Amido-thiazole-based compounds exhibiting ATP-utilizing enzyme inhibitory activity, and compositions, and uses thereof
03/09/2006US20060052411 Immunosuppressants, analgesics, antiinflammatory agents
03/09/2006US20060052392 Isoindoline derivative
03/09/2006US20060052384 Aryl piperidine derivatives as inducers of ldl-receptor expression for the treatment of hypercholesterolemia
03/09/2006US20060052374 Amino-tetrazole analogues and methods of use
03/09/2006US20060052372 N-(Heterocycloalkyl)alkylsulfonamides, e.g., N-[3-[4-(3-Chlorophenyl)piperazin-1-yl]propyl]-N-(4-methoxyphenyl)-propanesulfonamide; improve blood flow to the optic nerve head and the retina ; used to treat retinal diseases, sleep disorders, depression, schizophrenia, anxiety, OCD, etc.
03/09/2006US20060052366 Pyridine derivatives as fungicidal compounds
03/09/2006US20060052365 Protease inhibitors
03/09/2006US20060052360 Compounds, compositions and methods
03/09/2006US20060052358 Modulators of ATP-binding cassette transporters
03/09/2006US20060052349 Pyrrolo-naphthyl acids and methods for using them
03/09/2006US20060052348 such as ({6-[2-(2-naphthylmethyl)-1,3-oxazol-5-yl]-2-naphthyl}oxy)acetic acid, used to modulate plasminogen activator inhibitor (PAI-1) gene expression and to treat PAI-1 related disorders; cardiovascular and respiratory disorders; fibrosis, polycystic ovary syndrome, Alzheimer's disease, or cancer
03/09/2006DE102004042607A1 Substituierte Phenylaminothiazole und ihre Verwendung Substituted Phenylaminothiazole and their use
03/09/2006CA2578441A1 Pyrimidine sulphonamide derivatives as chemokine receptor modulators
03/09/2006CA2577495A1 Isoxazoline derivatives and their use as herbicides
03/09/2006CA2577275A1 Quinazolinone derivatives and their use as b-raf inhibitors
03/09/2006CA2576782A1 Methods of treatment of amyloidosis using substituted ethanolcyclicamine aspartyl protease inhibitors
03/09/2006CA2571989A1 Modulators of nuclear receptors
03/08/2006EP1632483A1 Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands
03/08/2006EP1632477A1 Benzamide derivative or salt thereof
03/08/2006EP1631567A2 Heterocyclic n-aryl carboxamides as cytokine inhibitors
03/08/2006EP1631562A1 Chromene derivatives as anti-inflammatory agents
03/08/2006EP1631561A2 Compositions and methods for non-invasive imaging of soluble beta-amyloid
03/08/2006EP1631558A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type i
03/08/2006EP1631551A2 Isoquinoline derivatives and their use as gfat inhibitors
03/08/2006EP1631549A2 3-[2-(3-amino-2-oxo-2h-pyridin-1-yl)-acetylamino]-4-oxo-pentanoic acid derivatives and their use as caspase inhibitors
03/08/2006EP1631548A2 Inhibitors of akt activity
03/08/2006EP1631542A1 Bicyclic compounds having bradykinin receptors affinity and pharmaceutical compositions thereof
03/08/2006EP1631292A1 4-anilino-quinazoline derivatives as antiproliferative agents
03/08/2006EP1631286A2 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
03/08/2006EP1631285A1 Therapeutic agents useful for treating pain
03/08/2006EP1482924A4 Cathepsin cysteine protease inhibitors
03/08/2006EP1446393B1 2-amino-thiazoline derivatives and their use as inhibitors of inducible no-synthase
03/08/2006EP1445252B1 Sulphonamide derivatives, the preparation thereof and the application of same as medicaments
03/08/2006EP1406628B1 Tetrahydroquinoline derivatives
03/08/2006EP1404667B1 Piperidine derivatives useful as modulators of chemokine receptor activity
03/08/2006EP1353908B1 Processes and synthetic intermediates for preparing n-arylacridancarboxylic acid derivatives
03/08/2006EP1318995B1 Pyridinone and pyridinethione derivatives having hiv inhibiting properties
03/08/2006EP1274407B1 Uses of ppar-gamma agonists in neutrophil-induced diseases
03/08/2006EP1261591B1 7-nitro-2,1,3-benzoxadiazole derivatives and 7-nitro-2,1,3-benzthiadiazole derivatives and dyes, which contain these compounds and which are used for dying keratin fibers
03/08/2006EP1242411B1 Indole derivatives for the treatment of depression and anxiety
03/08/2006EP1178967B1 Quinoline derivatives as inhibitors of mek enzymes
03/08/2006EP1176959B1 Novel prolines as antimicrobial agents
03/08/2006EP0930306B1 Bisthiadiazole derivatives and salts thereof, disease controlling agents for agricultural and horticultural use, and method for the use thereof
03/08/2006CN1745077A 促旋酶抑制剂及其用途 Gyrase inhibitors and their use
03/08/2006CN1745074A 5-HT receptor ligands and uses thereof